HIGHLIGHTS: Albert Bourla - CEO of Pfizer
Listen to the original audio · Transcribed with NVIDIA Parakeet · Why times can differ in your player
Hi everybody, tune in to this short version of the podcast, which we do every Friday. For the long version, tune in on Wednesdays. Hi everyone and welcome to In Good Company. I'm Nikolai Tangen, the head of the Norwegian Sovereign Wealth Fund, and today I'm in particularly good company because I'm here with Albert Burla, who is the chairman and CEO of Pfizer, one of the largest pharma companies in the world. Now Albert, he has been with Pfizer for 30 years, been CEO since 2019.
And has led the company through a remarkable period of change. Warm welcome. Thank you very much. And you know, I'm with Pfizer 33 years. I'm with my wife.
I'm with my wife 30. Oh, right. I I got it mixed up there. Yes, yes. Now a lot of stuff has happened since you took over as uh CEO.
We already have this episode, so unlocking it is cheap and permanent: the full transcript (9 minutes, 1,489 words), segment and word-level timestamps, and .txt, .srt, .vtt and word-level JSON downloads, as many times as you like, forever.
No account needed, we create one from your checkout email. With credits it is 1 credit; packs start at 5 episodes for $3.49, and monthly plans are cheaper still.